BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World J Gastroenterol 2019; 25(6): 659-671 [PMID: 30783370 DOI: 10.3748/wjg.v25.i6.659]
URL: https://www.wjgnet.com/1007-9327/full/v25/i6/659.htm
Number Citing Articles
1
Teresa Brevini, Olivia C. Tysoe, Fotios Sampaziotis. Tissue engineering of the biliary tract and modelling of cholestatic disordersJournal of Hepatology 2020; 73(4): 918 doi: 10.1016/j.jhep.2020.05.049
2
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practicesExpert Review of Gastroenterology & Hepatology 2021; 15(5): 487 doi: 10.1080/17474124.2021.1900732
3
Martina Taborelli, Michele Sozzi, Stefania Del Zotto, Federica Toffolutti, Marcella Montico, Loris Zanier, Diego Serraino, Jeffrey S. Chang. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern ItalyPLOS ONE 2020; 15(6): e0235142 doi: 10.1371/journal.pone.0235142
4
Lu Jiang, Peter Stärkel, Jian-Gao Fan, Derrick Eugene Fouts, Petra Bacher, Bernd Schnabl. The gut mycobiome: a novel player in chronic liver diseasesJournal of Gastroenterology 2021; 56(1): 1 doi: 10.1007/s00535-020-01740-5
5
Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, Guido Carpino, Luca Fabris, Enrico Gringeri, Vincenza Granata, Massimiliano Mutignani, Helen Morement, Felice Giuliante, Alfredo Guglielmi, Lorenzo Ridola, Marco Marzioni, Gianluca Grazi, Maria Guido, Emilio Di Giulio, Giuseppe Tonini, Francesco Pantano, Rosanna Venere, Maria Consiglia Bragazzi, Francesca Biancanello, Jessica Faccioli, Aurora Giannetti, Marcello Cintolo, Michela Di Giunta, Martina Gambato, Alberto Lasagni, Francesco Izzo, Antonio Avallone, Jesus Banales, Massimo Rossi, Carlo Catalano, Andrea Laghi, Giulia D'amati, Maria Grazia Mancino, Lorenzo Ridola. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and stagingDigestive and Liver Disease 2020; 52(11): 1282 doi: 10.1016/j.dld.2020.06.045
6
Gautham Appanna, Yiannis Kallis. An update on the management of cholestatic liver diseasesClinical Medicine 2020; 20(5): 513 doi: 10.7861/clinmed.2020-0697
7
Karoly Viragh, Maitraya Patel, Shaden Mohammad, Monica Deshmukh, Anokh Pahwa. Diagnosis and Management of Cholangiocarcinoma2021; : 179 doi: 10.1007/978-3-030-70936-5_7
8
Sohini Das, Manoj Job, Thomas Kodiatte, Ramya Iyadurai. Atypical presentation of intrahepatic cholangiocarcinoma---Fever and ascites in a postpartum ladyJournal of Family Medicine and Primary Care 2019; 8(11): 3748 doi: 10.4103/jfmpc.jfmpc_748_19
9
Dominic Staudenmann, Mark Bonnichsen, Payal Saxena, Arthur John Kaffes. Endoscopic Evaluation of Indeterminate Biliary Strictures: a ReviewCurrent Treatment Options in Gastroenterology 2021; 19(2): 308 doi: 10.1007/s11938-021-00339-w
10
David M. Chascsa, Keith D. Lindor. Cancer risk, screening and surveillance in primary sclerosing cholangitisMinerva Gastroenterologica e Dietologica 2019; 65(3) doi: 10.23736/S1121-421X.19.02586-8
11
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategyWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1229-1243 doi: 10.4251/wjgo.v13.i10.1229
12
Hanlai Zhang, Yonghong Gao, Liqin Wang, Li Tian, Na An, Xinyu Yang, Xinye Li, Chao Tian, Mengchen Yuan, Xingjiang Xiong, Nian Liu, Hongcai Shang, Yanwei Xing. Does heart failure increase the risk of incident cancer? A meta-analysis and systematic reviewHeart Failure Reviews 2020; 25(6): 949 doi: 10.1007/s10741-019-09876-0
13
Xiaohui Wang, Ting Fu, Junqiao Wang, Changyuan Wang, Kexin Liu, Jingjing Wu, Huijun Sun, Xiaodong Ma, Pengyuan Sun, Qiang Meng. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activationInternational Immunopharmacology 2019; 75: 105833 doi: 10.1016/j.intimp.2019.105833
14
Brian M. Fung, James H. Tabibian. Cholangiocarcinoma in patients with primary sclerosing cholangitisCurrent Opinion in Gastroenterology 2020; 36(2): 77 doi: 10.1097/MOG.0000000000000616
15
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional FrameworkAmerican Journal of Gastroenterology 2020; 115(6): 814 doi: 10.14309/ajg.0000000000000604
16
Mohammad Mawardi, Abduljaleel Alalwan, Hind Fallatah, Faisal Abaalkhail, Mohammed Hasosah, Mohammad Shagrani, MohammedY Alghamdi, AbdullahS Alghamdi. Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and TransplantationSaudi Journal of Gastroenterology 2021; 27(7): 1 doi: 10.4103/sjg.sjg_112_21
17
Atit Silsirivanit, Chatchai Phoomak, Sopit Wongkham. Diagnosis and Management of Cholangiocarcinoma2021; : 527 doi: 10.1007/978-3-030-70936-5_25
18
S. Franssen, D. M. de Jong, L. M. J. W. van Driel, B. Groot Koerkamp. Diagnosis and Management of Cholangiocarcinoma2021; : 229 doi: 10.1007/978-3-030-70936-5_9
19
Mario Altieri, Olivier Sérée, Thierry Lobbedez, Philippe Segol, Armand Abergel, Xavier Blaizot, Olivier Boillot, Karim Boudjema, Audrey Coilly, Filomena Conti, Olivier Chazouillères, Maryline Debette-Gratien, Sébastien Dharancy, François Durand, Christophe Duvoux, Claire Francoz, Jean Gugenheim, Jean Hardwigsen, Pauline Houssel-Debry, Nassim Kamar, Marianne Latournerie, Pascal Lebray, Vincent Leroy, Martine Neau-Cransac, Georges-Philippe Pageaux, Sylvie Radenne, Ephrem Salamé, Faouzi Saliba, Didier Samuel, Claire Vanlemmens, Camille Besch, Guy Launoy, Jérôme Dumortier. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patientsClinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101514 doi: 10.1016/j.clinre.2020.07.019
20
Francesca Saffioti, Vasileios K Mavroeidis. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitisWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1336-1366 doi: 10.4251/wjgo.v13.i10.1336
21
Taylor D. Ellington, Behnoosh Momin, Reda J. Wilson, S. Jane Henley, Manxia Wu, A. Blythe Ryerson. Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017Cancer Epidemiology Biomarkers & Prevention 2021; 30(9): 1607 doi: 10.1158/1055-9965.EPI-21-0265
22
Kazuma Daiku, Kazuto Fukuda, Osakuni Morimoto, Daisuke Takiuchi, Hiromi Shimakoshi, Tadashi Kegasawa, Yoshitaka Yamaguchi, Sachiyo Kogita, Yoshiyuki Sawai, Masanori Nakahara, Takumi Igura, Kunitaka Shibata, Yasuharu Imai. Primary adenosquamous carcinoma of the liver detected during cancer surveillance in a patient with primary sclerosing cholangitisClinical Journal of Gastroenterology 2020; 13(6): 1273 doi: 10.1007/s12328-020-01204-6
23
Dustin E. Bosch, Yoh Zen, Sarag A. Boukhar, Yongjun Liu, Lin Cheng, Matthew M. Yeh. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging settingVirchows Archiv 2021;  doi: 10.1007/s00428-021-03183-6
24
Rohit Das, Harkirat Singh, Adam Slivka. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy2020; : 1 doi: 10.1007/978-3-030-29964-4_80-1
25
Rebecca Little, Eytan Wine, Binita M Kamath, Anne M Griffiths, Amanda Ricciuto. Gut microbiome in primary sclerosing cholangitis: A reviewWorld Journal of Gastroenterology 2020; 26(21): 2768-2780 doi: 10.3748/wjg.v26.i21.2768
26
Lei Huang. 2020 International Conference on Applications and Techniques in Cyber IntelligenceAdvances in Intelligent Systems and Computing 2021; 1244: 180 doi: 10.1007/978-3-030-53980-1_27
27
Juan E. Corral, Kristopher P. Croome, Andrew P. Keaveny, Bhaumik Brahmbhatt, Paul T. Kröner, Karn Wijarnpreecha, Rohan M. Goswami, Massimo Raimondo, Michael B. Wallace, Yan Bi, Omar Y. Mousa. A 3-Decade Analysis of Pancreatic Adenocarcinoma After Solid Organ TransplantPancreas 2021; 50(1): 54 doi: 10.1097/MPA.0000000000001722
28
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 321 doi: 10.1016/bs.acr.2020.10.005
29
Ahmad Hassan Ali, Elizabeth J. Carey. Diagnosis and Management of Cholangiocarcinoma2021; : 435 doi: 10.1007/978-3-030-70936-5_20
30
Brigida Barberio, Davide Massimi, Nora Cazzagon, Fabiana Zingone, Alexander C. Ford, Edoardo V. Savarino. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysisGastroenterology 2021;  doi: 10.1053/j.gastro.2021.08.032
31
Silvia Cagnin, James H. Tabibian, Luca Fabris. Diagnosis and Management of Cholangiocarcinoma2021; : 251 doi: 10.1007/978-3-030-70936-5_10
32
Stanisław Rządkowski, Agnieszka Chmielińska, Marek Pacholczyk, Beata Łągiewska. Colonoscopy Surveillance in Liver Transplant Recipients for Primary Sclerosing Cholangitis Associated With Inflammatory Bowel DiseaseTransplantation Proceedings 2020; 52(8): 2484 doi: 10.1016/j.transproceed.2020.01.116
33
Roongruedee Chaiteerakij. Diagnosis and Management of Cholangiocarcinoma2021; : 137 doi: 10.1007/978-3-030-70936-5_5
34
Zuzanna Lukasik, Dirk Elewaut, Koen Venken. MAIT Cells Come to the Rescue in Cancer Immunotherapy?Cancers 2020; 12(2): 413 doi: 10.3390/cancers12020413
35
Fiona Hand, Emir Hoti. Contemporary role of liver transplantation for the treatment of cholangiocarcinomaExpert Review of Gastroenterology & Hepatology 2020; 14(6): 475 doi: 10.1080/17474124.2020.1765771
36
Itzel Medina-Andrade, Jonadab E. Olguín, Tonathiu Rodríguez, Luis I. Terrazas. Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives2021; : 103 doi: 10.1016/B978-0-12-822028-3.00003-0
37
Patrick F. van Rheenen. Managing abnormal liver tests in children with inflammatory bowel diseaseCurrent Opinion in Pediatrics 2021; 33(5): 521 doi: 10.1097/MOP.0000000000001045
38
Vinay K. Kapoor. A Pictorial Treatise on Gall Bladder Cancer2021; : 35 doi: 10.1007/978-981-15-5289-2_4
39
Morten D. Jensen, Peter Jepsen, Hendrik Vilstrup, Lisbet Grønbæk. Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort StudyAmerican Journal of Gastroenterology 2021;  doi: 10.14309/ajg.0000000000001525
40
Gabriel Mosquera-Klinger, Nathalie Yepes Madrid, Jhon Jaime Carvajal Gutiérrez. Enfermedad de Crohn con compromiso extenso y manifestaciones extradigestivas inusuales: a propósito de un caso Revista colombiana de Gastroenterología 2021; 36(Supl. 1): 85 doi: 10.22516/25007440.605